Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Nitroprusside for Spatial Working Memory in Schizophrenia
NCT02176044Phase 1Completed
- Sponsor
- King's College London
- Start
- Aug 2014
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of sodium nitroprusside in schizophrenia and schizoaffective disorder (2 arms), sponsored by King's College London. Primary endpoint: Spatial Working Memory at 4 hours. Started Aug 2014; status: completed.
02
Drugs
sodium nitroprusside
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT02176044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02176044.